title: Bronchopulmonary dysplasia: a review.
abstract: BACKGROUND
  The prevalence of bronchopulmonary dysplasia (BPD), one of the most frequently occurring complications following preterm birth, is increasing due to increased survival of preterm infants.
  
  
  METHODS
  Systematic literature review.
  
  
  CONCLUSIONS
  The etiology is multifactorial, with prematurity being a prerequisite for the development of BPD. Over time, there have been many different and new treatment modalities, some of them have reduced the severity of the disease, but none of them have been able to impact upon the increasing incidence of BPD.
authors: University Department of Pediatrics, Section 531, Hvidovre Hospital, Kettegaard Alle, DK-2650 Hvidovre, Copenhagen, Denmark. zarqa_ali@hotmail.com
authors: Zarqa
authors: Z
authors: Ali
authors: Peter
authors: P
authors: Schmidt
authors: James
authors: J
authors: Dodd
authors: Dorthe Lisbeth
authors: DL
authors: Jeppesen
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001724:Birth Weight; D001997:Bronchopulmonary Dysplasia / Q000209:etiology* / Q000235:genetics / Q000517:prevention & control / Q000628:therapy*; D002110:Caffeine / Q000627:therapeutic use; D005260:Female; D005865:Gestational Age; D006801:Humans; D018496:Hyperoxia / Q000150:complications; D007231:Infant, Newborn; D010102:Oxygen Inhalation Therapy; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D011663:Pulmonary Surfactants / Q000627:therapeutic use; D012121:Respiration, Artificial / Q000009:adverse effects; D012737:Sex Factors; D014801:Vitamin A / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D010726:Phosphodiesterase Inhibitors; D011663:Pulmonary Surfactants; D014815:Vitamins; D014801:Vitamin A; D002110:Caffeine